cancer

Have you ever been to a snooty cocktail party (1) and ordered a Diet Coke from the bar only to get the look?

Join Cameron English and Dr. Chuck Dinerstein as they examine a case of opioid research with "a side of corruption" on Episode 62 of the Science Dispatch podcast:

“The world’s largest review on opioid medicines for cancer pain has found it is unclear whether some commonly used opioid medicines are better than a placebo and suggests that nonopioid medicines, including aspirin, may b

Join hosts Cameron English and Dr. Chuck Dinerstein as they break down these stories on Episode 46 of the Science Dispatch podcast:

Join host Cameron English as he sits down with Dr. Chuck Dinerstein to break down these stories on Episode 43 of the Science Dispatch podcast:

The practice of medicine is often far from straightforward, and simple logic can mislead.  For example, elevated values of the widely used Prostate-Specific Antigen, or PSA, blood test are considered an early indicator of prostate cancer

Many people think of cancer as a single disease, and for many years the only treatment was to cut out tumor tissue that could be seen.  However, the history of cancer is that we have gradually subdivided malignancies into multiple categories.

For many years, the science communication landscape looked something like this: reputable universities and public health institutions did sound research and educated consumers about the risks they faced; devious activist groups fabricated health s

Join our directors of bio-sciences and chemistry, Cameron English and Dr. Josh Bloom, as they break down these stories on episode 24 of the Science Dispatch podcast.

Unlike stopping a pathogen with an antibiotic or antiviral drug, a process that is simple and well-understood, getting a handle on the seemingly impossible complexity of cancer cannot be more different.